国产激情久久久久影院小草_国产91高跟丝袜_99精品视频99_三级真人片在线观看

醫(yī)學專業(yè)論文參考文獻

時間:2023-07-29 14:35:37 歐敏 參考文獻 我要投稿
  • 相關推薦

醫(yī)學專業(yè)論文參考文獻

  從小學、初中、高中到大學乃至工作,大家都嘗試過寫論文吧,論文是指進行各個學術領域的研究和描述學術研究成果的文章。那么你知道一篇好的論文該怎么寫嗎?以下是小編收集整理的醫(yī)學專業(yè)論文參考文獻,希望對大家有所幫助。

醫(yī)學專業(yè)論文參考文獻

  醫(yī)學論文參考文獻一:

  [1]高松柏.國際嬰幼兒食品研究新動態(tài)[J].中國乳品工業(yè),2007(4):36-40.

  [2]趙學偉.食品擠壓膨化機理研宄進展[J].糧食加工,2010,35 (2) :59-65.

  [3]丁小林.大豆食品的營養(yǎng)價值與功能特性[J].食品研宄與開發(fā),2004,25,(6):101.

  [4]韓立德,蓋鈞鎰,張文明.大豆營養(yǎng)成分研究現(xiàn)狀[J].種子,2003(5): 58.

  [5]夏劍秋,張毅方.大豆中主要營養(yǎng)成分和微量元素的功能作用[J].中國油脂,2007,3(1):72.

  [6]姜中航,嬰兒配方奶粉生產(chǎn)中部分應用大豆分離蛋白的研宂[J].大豆科技,2009(2):41-43.

  [7]高連勝,李鐵紅,崔洪濱,等.適合嬰兒配方奶粉用蛋白的研宄[J].食品工業(yè),2009(4):52.

  [8]張瑞巖.豆基嬰兒配方粉的研究[D].東北農(nóng)業(yè)大學,2009.

  [9]張連慧.大豆分離蛋白在乳及乳制品中的應用[J].食品安全導刊,2009(5): 46.

  [10]陳莉.無糖速溶速凝豆奶粉的研制[D].江南大學,2005.

  [11]朱彥群,倪群.牛奶大豆雙蛋白營養(yǎng)酸奶的研究[J].食品研究與開發(fā),2007,28(4) :110-111.

  [12]高蟬,高連勝.大豆分離蛋白在嬰兒配方粉中的應用研宄[J].中國乳業(yè).2008(3)56-58.

  [13]汪之頊.葉黃素和玉米黃質對視覺發(fā)育和健康的影響[J].國外醫(yī)學衛(wèi)生學分冊.2008(3): 154-159.

  [14]李忠海,李安平.嬰幼兒營養(yǎng)米粉配方的優(yōu)化設計[J].中南林學院學報,2001,21(1):54-57.

  [15]AnastaseH. Evaluation of rice flour modified by extrusion cooking [J]. Journal ofcereal Science, 2006(43) :38-46.

  [16]MercedsB,ConsueloM,PerezO, etal. Varietal differences in properties of extrusioncooked rice flour[J]. Food Chemistry, 1986, 19(3): 173-187.

  醫(yī)學論文參考文獻二:

  [1]陸紅梅.視疲勞中醫(yī)理論探討及用藥規(guī)律分析[D];揚州大學,2010.

  [2]葉建東.視疲勞診斷、病因及其治療的研究進展[J].中國療養(yǎng)醫(yī)學,2014,03): 210-2.

  [3]張仁.透刺為主治療視疲勞的臨床觀察[J].上海針灸雜志,2007,09): 9-11.

  [4]李尖.視屏顯示終端與視疲勞及潘光不正[J].臨床醫(yī)藥實踐,2006,08):589-91.

  [5]張秀云.新型飲食療法對2型糖尿病患者的干預效果[J].中華護理雜志,2004, 10): 22-4.

  [6]張廣琴.中青年視疲勞與視屏終端[J].大家健康(學術版),2011,19):16-7.

  [7]陳麗君.利用傳統(tǒng)醫(yī)學經(jīng)絡調理法改善視疲勞的臨床觀察[D];北京中醫(yī)藥大學,2011.

  [8]潘小云.加味六君子湯治療視疲勞40例療效觀察[J].浙江中醫(yī)雜志,2010,02): 130.

  [9]黃文剛.中藥熏蒸聯(lián)合眼部穴位按摩改善視疲勞癥狀的療效觀察[J].中國中醫(yī)眼科雜志,2014,04): 251-4.

  [10]Johnson E J. A biological role of lutein [J]. Food Rev Int,2004,20(1); 1-16.

  [11]Christen W Q Liu S,Glynn R J,et al. Dietary carotenoids, vitamins C and E, and risk of cataract in women [J]. Arch Ophthalmol, 2008, 126(1): 102-9.

  [12]Bone R A,Landrum J T,Dixon Z,et al. Lutein and zeaxanthin in the eyes,serum and diet of human subjects [J]. Exp Eye Res, 2000,71(3): 239-45.

  醫(yī)學論文參考文獻三:

  [1]程牛亮.生物化學[M].北京:高等教育出版社,2011:299-311.]

  [2]毛羽揚.食鹽在烹飪調味中的作用[J].中國調味品,1999,5.

  [3]巖瀨榮一.鹽及其化學[M].北京:輕工業(yè)出版社,1960:10-36.

  [4]蘇敬.新修本草[M].群聯(lián)出版社,1955.

  [5]金明宮.竹鹽的烤熔熏制法[J].中小企業(yè)科技,2003,7:019.

  [6]潘進富,張成霞.化學教育[M].1999,20 (6):3-4.

  [7]李衛(wèi)平.功能性保健食鹽的開發(fā)研究[J].海湖鹽科技資料,2000(8):1-6.

  [8]王琦.王琦方藥應用31論[M].2012:250-267.

  [9]陳敏章,邵丙楊.中華內科學[M],北京:人民衛(wèi)生出版社,2006:2477-2481.

  [10]高欽穎.韓國仁山竹鹽治療胃病15例[J].陜西中醫(yī),1994,15(7):298.

  [11]美國NKF-K/DOQI工作組.慢性腎臟病及透析的臨床實踐指南[M].北京:人民衛(wèi)生出版社,2003(1).

  [12]郭義敏,劉穎,陳歷明.近端腎小管碳酸氫根重吸收的分子機制及代謝性酸中毒[J].生理學報,2014,66(4): 398~414.

  [13]Moon, et al. The Intrinsic Antimicrobial Activity of Bamboo Salt against Salmonella enteritidis[J]. Molecular and Cellular Toxicology, 2010,6(1): 109-109.

  醫(yī)學論文參考文獻

  [1]Weaver A., da Silva A. G, Nuttall R. K.,et al. An elevated matrix metalloproteinase(MMP) in an animal model of multiple sclerosis is protective by affecting Thl/Th2polarization. The FASEB journal. 2005. 19(12): p. 1668-1670.

  [2]Venteo L_,Bourlet T” Renois F” et al. Enterovirus-related activation of thecardiomyocyte mitochondrial apoptotic pathway in patients with acute myocarditis.European heart journal. 2010. 31(6): p. 728-736.

  [3]Rose N. R. The adjuvant effect in infection and autoimmunity. Clinical reviews inallergy & immunology. 2008. 34(3): p. 279-282.

  [4]陳瑞珍,解玉泉.病毒性心肌炎向擴張型心肌病演變的免疫學機制.診斷學理論與實踐-2012. 10(5): p. 414-417.

  [5]Camporeale A., Marino F” Papageorgiou A.,et al. STAT3 activity is necessary andsufficient for the development of immune “ mediated myocarditis in mice andpromotes progression to dilated cardiomyopathy. EMBO molecular medicine. 2013.5(4): p. 572-590.

  [6]Zhu J.,Paul W. E. CD4 T cells: fates, functions, and faults. Blood. 2008. 112(5): p.1557-1569.

  [7]Korn T.,Bettelli E?,Oukka M.,et al. IL-17 and Thl7 Cells. Annual review ofimmunology. 2009. 27: p. 485-517.

  [8]Yu Y” Liu Y-,Shi F.-D., et al. Cutting edge: leptin-induced RORyt expression in CD4+T cells promotes Thl7 responses in systemic lupus erythematosus. The Journal ofImmunology. 2013. 190(7): p. 3054-3058.

  [9]van Bruggen N.,Ouyang W. Thl7 Cells at the Crossroads of Autoimmunity,Inflammation, and Atherosclerosis. Immunity. 2014. 40(1): p. 10-12.

  [10]Annnn2:iatoF., Cosmi L., Santarlasci V.,et al. Phenotypic and functional features ofhuman Thl7 cells. The Journal of experimental medicine. 2007. 204(8): p. 1849-1861.

  [11]ShahraraS.,Huang Q.,Mandelin II A. M.,et al. TH-17 cells in rheumatoid arthritis.Arthritis Research and Therapy. 2008. 10(4): p. R93.

  [12]KomiyamaY.,Nakae S.,Matsuki T_,et al. IL-17 plays an important role in thedevelopment of experimental autoimmune encephalomyelitis. The Journal ofImmunology. 2006. 177(1): p. 566-573.

  [13]Bettelli E” Carrier Y?,Gao W,et al. Reciprocal developmental pathways for thegeneration of pathogenic effector TH17 and regulatory T cells. Nature. 2006.441(7090): p. 235-238.

  [14]VeldhoenM.,Hocking R. J.,Atkins C. J.,et al. TGFp in the context of aninflammatory cytokine milieu supports de novo differentiation of IL-17-producing Tcells. Immunity. 2006. 24(2): p. 179-189.

  [15]ManganP. R., Harrington L. E.,OQuinn D. B.,et al. Transforming growth factor-pinduces development of the TH17 lineage. Nature. 2006. 441(7090): p. 231-234.

  [16]AkimzhanovA. M.,Yang X. 0.,Dong C. Chromatin remodeling of interleukin-17(IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation.Journal of biological chemistry. 2007. 282(9): p. 5969-5972.

  [17]NurievaR” Yang X. 0” Martinez G,et al. Essential autocrine regulation by IL-21 inthe generation of inflammatory T cells. Nature. 2007. 448(7152): p. 480-483.

  [18]Yang L,Anderson D. E.,Baecher-Allan C.,et al. IL-21 and TGF-&bgr; are requiredfor differentiation of human TH17 cells. Nature. 2008.454(7202): p. 350-352.

  [19]TrinchieriG,Pflanz S.,Kastelein R. A. The IL-12 family of heterodimeric cytokines:new players in the regulation of T cell responses. Immunity. 2003. 19(5): p. 641-644.

  [20]Zhou L,Ivanov I. I,Spolski R?,et al. IL?6 programs TH-17 cell differentiation bypromoting sequential engagement of the IL-21 and IL-23 pathways. Natureimmunology. 2007. 8(9): p. 967-974.

  [21]AggarwalS” Ghilardi N., Xie M.-H.,et al. Interleukin-23 promotes a distinct CD4 Tcell activation state characterized by the production of interleukin-17. Journal ofBiological Chemistry. 2003. 278(3): p. 1910-1914.

  [22]Harrington L. E., Hatton R. D.,Mangan P. R.,et al. Interleukin 17—producing CD4+effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.Nature immunology. 2005. 6(11): p. 1123-1132.

  [23]Yang X. 0., Panopoulos A. D.,Nurieva R.,et al. STAT3 regulates cytokine-medlatedgeneration of inflammatory helper T cells. Journal of Biological Chemistry. 2007.282(13): p. 9358-9363.

  [24]LaurenceA.,Tato C. M.,Davidson T. S?,et al. Interleukin-2 signaling via STAT5constrains T helper 17 cell generation. Immunity. 2007. 26(3): p. 371-381.

  [25]EberlG,Marmon S.,Sunshine M.-J.,et al. An essential function for the nuclearreceptor RORyt in the generation of fetal lymphoid tissue inducer cells. Natureimmunology. 2004. 5(1): p. 64-73.

  [26]Yang X. 0” Pappu B. P.,Nurieva R., et al. T helper 17 lineage differentiation isprogrammed by orphan nuclear receptors RORa and RORy. Immunity. 2008. 28(1): p.29-39.

  [27]IvanovI. I.,McKenzie B. S.,Zhou L.,et al. The Orphan Nuclear Receptor RORytDirects the Differentiation Program of Proinflammatory IL-17< sup>+ T HelperCells. Cell. 2006. 126(6): p. 1121-1133.

  [28]QingK.,Weifeng W” Fan Y?,et al. Distinct different expression of Thl7 and Th9 cellsin coxsackie virus B3-induced mice viral myocarditis. Wol J. 2011. 8: p. 267.

  [29]Jiang N.,Liao W”Kuang X. Effects of emodin on IL-23/IL-17 inflammatory axis,Thl7 cells and viral replication in mice with viral myocarditis. Nan Fang Y Ke DaXue Xue Bao. 2014. 34(3): p. 373-378.

  [30]Yang F.,Wu W.-F.,Yan Y.-L.,et al. Expression of il-23/thl7 pathway in a murinemodel of coxsackie virus b3-induced viral myocarditis. Virology journal. 2011. 8(1): p.301.

  [31]FanY” Weifeng W., Yuluan Y” et al. Treatment with a neutralizing anti-murineinterleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditisreduces myocardium inflammation. Virol J. 2011. 8(1): p.17.

  [32]Yu M.5 Hu J” Zhu M. X.,et al. Cardiac fibroblasts recruit Thl7 cells infiltration intomyocardium by secreting CCL20 in CVB3-induced acute viral myocarditis. CellPhysiol Biochem. 2013. 32(5): p, 1437-1450.

  [33]XieY.,Chen R.,Zhang X.,et al. The role of Thl7 cells and regulatory T cells inCoxsackievirus B3-induced myocarditis. Virology. 2011. 421(1): p. 78-84.

  [34]YuanJ., Yu M., Lin Q.-W., et al. Thl7 cells contribute to viral replication incoxsackievirus B3-induced acute viral myocarditis. The Journal of Immunology. 2010.185(7): p. 4004-4010.

  [35]YuanJ.,Cao A.-L., Yu M.,et al. Thl7 cells facilitate the humoral immune response inpatients with acute viral myocarditis. Journal of clinical immunology. 2010. 30(2): p.226-234.

  [36]Yuan J” Yu M.,Lin Q.-W., et al. Neutralization of IL-17 inhibits the production ofanti-ANT autoantibodies in CVB3-induced acute viral myocarditis. Internationalimmunopharmacology. 2010.10(3): p. 272-276.

  [37]Liu Y?,Zhu H?,Su Z.,et al. IL-17 contributes to cardiac fibrosis followingexperimental autoimmune myocarditis by a PKCbeta/Erkl/2/NF-kappaB_dependentsignaling pathway. Int Immunol. 2012. 24(10): p. 605-612.

  [38]BaldevianoG C., Barin J. G,Talor M. V” et al. Interleukin-17A is dispensable formyocarditis but essential for the progression to dilated cardiomyopathy. Circulationresearch. 2010. 106(10): p. 1646-1655.

【醫(yī)學專業(yè)論文參考文獻】相關文章:

物流論文參考文獻03-30

農(nóng)業(yè)論文參考文獻08-27

mysql論文參考文獻03-03

數(shù)學教學的論文參考文獻06-14

教育教學論文參考文獻06-14

體育專業(yè)論文參考文獻03-09

數(shù)學教學論文參考文獻04-03

科技論文參考文獻格式04-25

web論文參考文獻參考04-25

論文參考文獻的基本格式11-18